Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

VIDEO: Focused On Past Producing Gold Mines in Quebec

Philippe Cloutier, President & CEO of Cartier Resources discusses how the companies main focus is exploring for gold in the Abitibi Greenstone Belt. “Our main focus is gold. Exploring for gold in the Abitibi Greenstone Belt, the Quebec portion ...

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer. Clinical-stage biopharmaceutical company Mersana Therapeuti...

Silver Offers A Golden Opportunity To Preserve Soon To Be Destroyed Value

The fundamentals for silver and gold are very strong, and with all the massive bailouts and stimulus, which have increased debt levels, they are just getting stronger. Until a significant portion of these debts is repaid or defaulted on, it would be foolish to talk about a to...

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. In a March 26 research note, analyst Joseph Pantginis reported that IMV Inc.'s (IMV:TSX; IMMVD:OTCQX) preliminary monotherapy data confirmed the efficacy o...

Delrey Metals Goes Definitive on a Blockbuster Vanadium/Iron/Titanium Property

Delrey Metals Corp. (CSE: DLRY) / (OTC: DLRYF) owns 100% of 5 promising properties in Canada. Four are prospective for vanadium, totaling 10,856 hectares, one is a cobalt–copper-zinc opportunity that Cobalt 27 Capital Corp . acquired a 2% NSR on. In addition, on May 21st, ...

Global Dow Nails Down Bullish Signal

SIGN OF GROWING CONFIDENCE At the end of November, monthly CCI completed a momentum round trip by closing above 100 after closing below -100 in late 2018. CCI helps us track market momentum. The turn that just took place over the last year is typically associated with a si...

This Highly Successful Abitibi Gold Explorer Continues to Produce Results

With the gold price hovering in and around the USD$2000 mark for the past few months, gold exploration companies are beginning to ramp up operations. Not every company can boast about having historically-producing properties in a mining-friendly jurisdiction, an experienced...

Canadian Gold Company Receives Plan of Operations for Idaho Asset

The scope of the permit is described in this Haywood report. In a Feb. 20 research note, analyst Mick Carew reported that, in an "important milestone," Liberty Gold Corp. (LGD:TSX) received the plan of operations (POO) for Black Pine, a "highly prospective project sim...

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. In a March 18 research note, H.C. Wainwright & Co. analyst Andrew Fein purported that Constellation Pharmaceuticals Inc.'s (CNST:NASDAQ) "strong and balanced pi...
1 2 3 4 5 6 7 8 9 10 ...